Keppra 250 Mg 30 Tablets

Keppra 250 Mg 30 Tablets

Description:

Keppra 250 mg 30 tablets is a prescription anticonvulsant medicine containing levetiracetam, used for the treatment and control of epilepsy and seizures. It is formulated as film‑coated tablets for oral use and is commonly prescribed as monotherapy or adjunctive therapy in adults and children with various types of seizures. Keppra helps stabilize abnormal electrical activity in the brain, reducing the frequency and severity of epileptic episodes and supporting long‑term seizure management under medical supervision.

Indications:

• Treatment of partial-onset (focal) seizures with or without secondary generalization in adults, adolescents, and children as prescribed by a doctor.
• Adjunctive therapy in myoclonic seizures in patients diagnosed with juvenile myoclonic epilepsy (as directed by a neurologist).
• Adjunctive therapy in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy.
• Helps reduce seizure frequency and intensity, supporting better daily functioning and quality of life for people with epilepsy.

Active Ingredients / Key Components:

• Levetiracetam – 250 mg per film‑coated tablet.
• Excipients (tablet core and coating such as fillers, binders, and coloring agents) – exact composition and concentrations , please check the product leaflet or the manufacturer’s official website; please refer to the official package leaflet for full excipient list.

Dosage & Administration / How to Use:

• Keppra 250 mg tablets are for oral use only and must be taken exactly as prescribed by your doctor.
• Typical regimen: levetiracetam is usually taken twice daily, once in the morning and once in the evening, with or without food. The exact dose (in mg per day) and duration are individualized by the physician based on age, body weight, kidney function, and clinical response.
• Swallow the tablets whole with a glass of water; do not crush, break, or chew unless your doctor or pharmacist advises otherwise.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not take a double dose to make up for a forgotten dose.
• Do not stop taking Keppra suddenly without medical advice, as abrupt discontinuation may increase the risk of seizures. Dose reductions or discontinuation must be gradual and under medical supervision.
• Use in children: dosing is weight-based and strictly determined by the pediatric neurologist. Caregivers should follow the prescribed schedule carefully.
• Patients with kidney impairment may require dose adjustment; your doctor will determine the appropriate regimen after assessing renal function.

Clinical Benefits:

• Helps control and reduce the frequency of epileptic seizures by modulating abnormal neuronal activity in the brain.
• Can be used as monotherapy or in combination with other antiepileptic drugs, providing flexible treatment options tailored to patient needs.
• Generally has a predictable pharmacokinetic profile with minimal drug–drug interactions compared with some older antiepileptic medicines.
• Twice-daily dosing supports convenient long‑term management of epilepsy and may improve adherence to treatment when used as directed.

Warnings & Contraindications:

• Use only under the supervision of a qualified physician, preferably a neurologist. Keppra is a prescription medicine and should not be used without medical evaluation.
• Contraindicated in patients with known hypersensitivity or allergy to levetiracetam or any of the excipients in the formulation.
• May cause mood changes, irritability, anxiety, depression, or suicidal thoughts in some patients. Inform your doctor immediately if you or your caregiver notice significant changes in mood, behavior, or mental health.
• Caution in patients with a history of psychiatric disorders, severe behavioral problems, or suicidal ideation; close monitoring is recommended.
• Patients with kidney impairment require dose adjustment; inform your doctor if you have kidney disease or are on dialysis.
• Use during pregnancy and breastfeeding only if clearly needed and after careful risk–benefit assessment by your doctor. Do not start or stop treatment in pregnancy without medical advice.
• May cause drowsiness, dizziness, or coordination problems. Avoid driving, operating machinery, or performing tasks that require full alertness until you know how Keppra affects you.
• Avoid alcohol or other central nervous system depressants unless approved by your doctor, as they may increase side effects such as drowsiness or dizziness.
• Consult your doctor before use if you are pregnant, nursing, taking other medications (including other antiepileptics, sedatives, or psychiatric drugs), or have medical conditions such as kidney disease, psychiatric illness, or severe systemic disease.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision; it is specifically indicated for epilepsy as directed by a physician.
• Keep out of reach of children.

Side Effects:

• Common side effects may include drowsiness, fatigue, dizziness, headache, weakness, and gastrointestinal symptoms such as nausea or vomiting.
• Neuropsychiatric side effects can include anxiety, irritability, agitation, mood swings, depression, and, rarely, suicidal thoughts or behavior. Seek medical attention immediately if severe mood or behavior changes occur.
• Other possible effects may include sleep disturbances, loss of appetite, weight changes, tremor, or coordination difficulties.
• Hair loss has been reported in some patients using levetiracetam.
• Serious allergic reactions (rash, itching, swelling of the face or throat, severe dizziness, difficulty breathing) are rare but require urgent medical attention.
• This is not a complete list of side effects. Always read the patient information leaflet and consult your doctor or pharmacist if you experience any unusual or persistent symptoms.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack or original container tightly closed. Do not use after the expiry date printed on the pack. Keep out of reach of children.

Specifications:

• Product type: Prescription antiepileptic medicine (anticonvulsant).
• Strength: 250 mg levetiracetam per film‑coated tablet.
• Form: Film‑coated oral tablets.
• Pack size: 30 tablets per pack.
• Route of administration: Oral.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.